Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Am J Clin Pathol. 2013 Dec;140(6):838–844. doi: 10.1309/AJCPE4PK6CTBNQJY

Table 2. p63 is an independent predictor of MCC-specific survival.

Univariate and multivariate Cox regression analyses of MCC-specific mortality. HR: hazard ratio. 95% CI: 95% confidence interval.

Univariate Multivariate
HR (95% CI) P HR (95% CI) P
Stage II (vs. I) 1.91 (0.6-5.9) 0.27 2.33 (0.7-7.4) 0.16
Stage III (vs. I) 4.94 (2.0-12) <0.001 4.92 (2.0-12) <0.001
Stage IV (vs. I) 15.8 (5.2-48) <0.001 13.7 (4.3-44) <0.001
Female (vs. male) 0.53 (0.3-1.1) 0.07 0.67 (0.3-1.4) 0.27
Age at diagnosis
(per 5 years older)
1.11 (1.0-1.3) 0.10 1.04 (0.9-1.2) 0.61
p63 expressed in
tumor
2.05 (1.1-3.6) 0.02 2.05 (1.1-3.8) 0.02